ClinConnect ClinConnect Logo
Search / Trial NCT02801123

The MATCH Study: Mindfulness And Tai Chi for Cancer Health

Launched by LINDA E. CARLSON · Jun 10, 2016

Trial Information

Current as of August 11, 2025

Unknown status

Keywords

Complimentary Cancer Therapies Psychosocial Oncology Behavioural Medicine Mindfulness Based Cancer Recovery Tai Chi Qigong Mindfulness Based Stress Reduction Yoga Preference Based Trial

ClinConnect Summary

Background While there is ample research documenting the problems people diagnosed with cancer face, including high levels of distress, anxiety, depression and symptoms such as fatigue, pain and sleep disturbance, there is also a limited but growing body of evidence supporting the efficacy of a range of mind-body therapies (MBTs) in alleviating these and other symptoms. The investigators have chosen to focus on comparing MBCR and TCQ because both have level 1 evidence in cancer care, and both have shown potential to affect important biomarkers and clinical outcomes. Both interventions are s...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Men and women over the age of 18
  • 2. Diagnosed with any type of cancer (stage I-III) excluding head, neck, or brain
  • 3. Completed active treatment (i.e. surgery, chemotherapy, radiation therapy) at least 4 months previously (ongoing hormonal therapies, AIs, tamoxifen, herceptin are not exclusionary)
  • 4. Experiencing significant distress (4 or greater on the Distress Thermometer)
  • 5. Able to attend MBCR or TCQ classes at scheduled times
  • 6. Sufficient functional capacity to participate in intervention groups (as judged by PAR-Q questionnaire, study staff, participant and participant's physician)
  • 7. Ability to speak and write English sufficiently to complete questionnaires and participate in groups.
  • Exclusion Criteria:
  • 1. Metastatic patients and those with ongoing chemotherapy (because ongoing therapy may impair biomarker profiles, and metastatic patients may not be stable enough to participate in the interventions and follow-up assessments).
  • 2. Cognitive impairment that would interfere with completing questionnaires or the intervention.
  • 3. Suffering from current Major Depressive Disorder, Bipolar Disorder or other psychiatric disorder that would interfere with the ability to participate.
  • 4. Currently engages in meditation or tai chi one or more times per week
  • 5. Previous participation in MBCR program.

About Linda E. Carlson

Linda E. Carlson is a distinguished clinical trial sponsor renowned for her commitment to advancing healthcare research through innovative clinical studies. With a focus on exploring integrative approaches to cancer care and psycho-oncology, she leads initiatives that bridge the gap between psychological well-being and physical health outcomes. Her expertise in designing and managing clinical trials ensures rigorous methodologies and ethical standards, fostering collaboration among multidisciplinary teams. Carlson's work not only contributes to the scientific community but also aims to enhance patient quality of life and treatment experiences.

Locations

Calgary, Alberta, Canada

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Linda E Carlson, PhD

Principal Investigator

University of Calgary, Cancer Control Alberta, Alberta Health Services

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials